During active cancer treatment, patients face many smaller battles on the path to remission. One of those lesser-known struggles is a condition known as chemo mouth, a painful side effect of ...
Updated data "reinforce enfortumab vedotin and pembrolizumab as the new standard of care in frontline urothelial cancer,” said Thomas Powles, MD, MBBS.
She urged that someone undergoing chemotherapy should “use ... does not have cancer and is not receiving treatment could end up with dizziness, rash, nausea, vomiting, skin conditions, all ...
Other NHLs of the skin that produce a rash may need systemic therapy, such as chemotherapy or immunotherapy. These treatments are often given intravenously to attack cancer cells throughout the body.
Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...
The EV-302/KN-A39 trial demonstrated improved overall survival and PFS with Padcev and Keytruda compared to standard chemotherapy. Neuropathy, skin rash, and hyperglycemia following enfortumab vedotin ...